Abstract. The recent cloning of complete cDNAs encoding carcinoembryonic antigen (CEA) and nonspecific cross-reacting antigen has revealed the existence of a new gene family belonging to the immunoglobulin gene superfamily. We have reported the isolation of a partial CEA cDNA and of L-cell transfectant cell lines that express human antigens cross-reactive with commercial antibodies directed to native CEA (Kamarck, M., J. Elting, J. Hart, S. Goebel, P. M. M. Rae, J. Nedwin, and T. Barnett. 1987. Proc. Natl. Acad. Sci. USA. 84:5350-5354). In this study, we describe the identification and cloning of 3.9-, 3.7-, 2.2-, and 1.8-kb cDNAs and a 23-kb genomic transcription unit, which code for new members of the CEA gene family. DNA sequence analysis of these cloned DNAs establishes the existence of a set of four alternatively spliced mRNAs which are expressed in several tumor cell lines, in human fetal liver, and in L-cell transfectants. Deduced amino acid sequences of the encoded isoantigens show extensive similarity to CEA and nonspecific cross-reacting antigens, but in addition demonstrate transmembrane and cytoplasmic domains. We designate members of this antigen family transmembrane' CEAs. The transmembrane CEA isoantigens share general structural characteristics with members of the immunoglobulin gene superfamily and can be specifically compared to the cell adhesion molecules, N-CAM (neural cell adhesion molecule) and MAG (myelin-associated glycoprotein).
C
ARCINOEMBRYONIC antigen (CEA) ~ is a 180-kD glycoprotein that has been used extensively as a serum marker in some cancers, particularly those of colorectal, breast, and lung origin. Despite its initial promise as a tumor-specific marker, CEA has been shown to be a member of a family of 8-10 cross-reactive isoantigens which can be detected in a variety of normal and tumor tissue types (Shively and Beatty, 1985) . CEA and nonspecific crossreacting antigen (NCA) have recently been shown to have considerable structural and sequence similarity (Engvall et al., 1978; Paxton et al., 1987; Thompson et al., 1987) , thus explaining their observed immunological cross-reactivity among anti-CEA antibodies (von Kleist et al., 1972; Darcy et al., 1973) . This cross-reactivity extends to all members of the CEA isoantigen family and has made interpretation of diagnostic immunoassays for CEA both difficult and inaccurate.
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Recently, the complete cDNAs for both CEA and NCA have been isolated and sequenced (Beauchemin et al., 1987; Oikawa et al., 1987; Barnett et al., 1~88; Neumaier et al., 1988; Tawaragi et al., 1988) . These antigens display a high degree of sequence similarity and also maintain a repeating series of disulfide loops with features of immunoglobulin superfamily members (Hunkapiller and Hood, 1986; Williams and Barclay, 1988) . Both CEA and NCA have short hydrophobic peptide segments at their carboxyl termini, but appear to be anchored in the cell membrane by a glycolipid moiety (Takami et al., 1988) .
We have previously isolated an L-cell transfectant line, 23.4 11+, and a bacteriophage hgtll partial cDNA clone ()~cLV7) that express epitopes of CEA (Kamarck et al., 1987) . The partial cDNA clone encompasses the second and part of the third loop domains of CEA (nucleotides 1,084-1,916 in Barnett et al., 1988) and identifies several major Eco RI and Barn HI segments in genomic DNA. All of these genomic segments map to human chromosome 19, suggesting the existence of a CEA gene locus consisting of an extensive family of related members. In contrast, cDNA from hcLV7 hybridized to a single genomic segment in L-cells that had been transfected with human genomic DNA and selected for CEA expression using commercial antibod-ies and the fluorescence-activated cell sorter. These transfectants expressed CEA family members distinguishable from both CEA and NCA based on the molecular sizes of their antigens and their messenger RNAs (Kamarck et al., 1987; Barnett et al., 1988) .
In this study, we describe the cloning of a genomic transcription unit and of cDNAs for alternatively spliced mRNAs that code for four previously undescribed CEA isoantigens expressed by a number of tumor cell lines and by normal fetal liver. Despite their extensive amino acid sequence similarities, the four protein species differ from CEA and NCA in that they contain transmembrane and cytoplasmic domains. For this reason we have designated these molecules transmembrane CEAs (TM-CEAs). With the identification of this new class of CEA glycoproteins, we can now account for six of the 8-10 members of the CEA isoantigen family.
Materials and Methods

Cells and Cell Lines
Human tumor cell lines were obtained from the American Type Culture Collection (RockviUe, MD) and grown according to specifications. Line designations are LoVo (CCL 229, colon adenocarcinoma), HT-29 (HTB 38, colon adenocareinoma), BeWo (CCL 98, choriocarcinoma), SW403 (CCL 230, colon adenocarcinoma), KG-1 (CCL 246, acute myelogenous leukemia), SCaBER (HTB 3, squamous bladder carcinoma), and MIA PaCa-2 (CRL 1420, human pancreatic carcinoma). The L-cell transfectant line, 23.4 11+, has been previously described (Kamarek et al., 1987) .
D NA Preparation and Analysis
DNA was extracted from cells essentially as described by DiLella and Woo (1987) . DNA (10 #g) was digested at 37°C for 6-8 h with restriction endonucleases (Amersham Corp., Arlington Heights, IL) and subjected to electrophoresis through horizontal 0.8 % agarose gels before transfer to nylon membranes. For the preparation of genomic DNA for library construction or subeloning, 100-200 #g of DNA was digested either with excess Eco RI or with a predetermined amount of Mbo I (mean DNA size produced = 12-15 kb) and subjected to electrophoresis overnight through horizontal 0.5 % low melting temperature agarose gels for optimal separation. Appropriate size classes were excised with a razor blade, gel slices were melted in 0.3 M NaOAc, pH 5, and 0.1 M Tris-HCI, pH 7.8, DNA was purified by phenol extraction, precipitated with 95% ethanol, and resuspended in 10 mM Tris-HCl, pH 7.5, I mM EDTA.
RNA Preparation and Analysis
Cell pellets stored at -80°C were thawed in the presence of 0.14 M NaC1, 1.5 mM MgCI2, 10 mM Tris-HCl, pH 7.5, 0.5% NP-40 (Sigma Chemical Co., St. Louis, MO), 4 mM DTT, and 10 u/ml of human placental ribonuclease inhibitor (Stratagene Inc., San Diego, CA). Cells were fractionated by 20 strokes of a low clearance Dounce-type homogenizer and incuhated in 0.1% Na deoxycholate for 10 min on ice. Cytoplasmic and nuclear fractions were separated by centrifugation for 20 min at 12,000 g, and the supernatant was added to an equal volume of 200 mM Tris-HCl, pH 7.5, 25 mM EDTA, 300 mM NaC1, 2 % SDS, and 400/~g/ml of proteinase K. After incubation at 45 °C, nucleic acids were extracl~xt with phenol/chloroform (1:1 [vol/vol]), and ethanol precipitated in the presence of added NaOAc to 0.15 M. Poly A+ RNA was prepared by oligo dT column chromatography as described by Aviv and Leder (1972) . For Northern analysis, nucleic acids were separated on 2.2 M formaldehyde-0.8 % agarose gels as described by Lehrach et al. (1977) , then transferred to nylon membranes.
Probe Preparation and Nucleic Acid Blots
Mini-preparations of plasmid DNA (Maniatis et al., 1982) were digested with restriction enzymes and fractionated by size on 1% agarose gels. Appropriate segments were excised from the gel and used directly for random priming (Feinberg and Vogelstein, 1984) in the presence of ot-32p-dCTP (6,000 Ci/mmol; Amersham Corp). Unincorporated nucleotide was removed by spun column chromatography over Piscataway, N J) . Probes were used at 106 cpm/ml in 2 × SSPE, 5x Denhardt's, 6% SDS at 68°C for 24--48 h. Posthybridization washes were in 0.2x SSPE, 0.25% SDS at 68°C.
c D NA Library Construction
Poly A+ RNAs from 23.411+ transfectant cells and from HT-29 cells were converted to double-stranded DNA essentially by the method of Gubler and Hoffman (1983) . After Eco RI methylase treatment, DNA was fractionated on 0.8 % LGT agarose gels, size selected based on identification of RNA from Northern blots, and eluted by melting (see above). Eco RI linkers were added and cDNAs were inser~d into Eco RI-cleaved arms of liga~xl ~,gtl0 DNA. Phage with inserts were selected on the Hfl + host, NM514. Screening of phage was by the method of Benton and Davis (1977) using radiolabeled DNA probes. Purified positive phage DNAs were cleaved with Eco RI, then inserts were fractionated on 1% LGT agarose gels and ligated to 5 ng of Eco Rl-cleaved plasmid Bluescript KS+ (Stratagene). Plasmid minipreps were used as source of DNA for deriving nested deletion sets of cDNA inserts by exonuclease IlI/mung bean nuclease treatment (Henikoff, 1984) and/or for primer or oligonucleotide directed dideoxy sequencing on double-stranded DNA by the method of Sanger et al. (1977) . Computer-aided analysis of DNA sequence information was performed using the Pustell program (IBI) or the series of programs published by the Genetics Computer Group (Madison, WI).
Genomic Library Construction
DNA segments of 12-15 kb from Mbo I partial digests were inserted into left and right arms of Barn HI-cleaved Mam phage DNA. This Aam Barn bacteriophage vector was constructed by substituting the 5.0-kb cosL-Ava I segment of kCharon 4A phage DNA for the equivalent segment of MI DNA (Mullins et al., 1984) and selecting phage on su-/su + hosts. A library of >10 ~ independent recombinants was obtained after packaging the ligated hJam and transfectant DNAs in vitro and plating on Escherichia coil host LE392. Positive phage were purified, DNAs were prepared, and restriction segments were separated on 1% agarose gels before blotting on nitrocellulose membranes according to Southern (1975) . Appropriate segments were subeloned into Bluescribe (-) or Bluescript KS+ or SK+ plasraids for double-stranded DNA sequencing.
Western Blot Analysis
Peptide/N-glycanase was purified from culture supernatants of Flavobacterium meningosepticum by the method of Tarentino et al. (1985) . No endoglycosidase F or endogenous protease activity could be demonstrated in this preparation. Transfectant 23.4 11+ or normal mouse L cells were lysed in phosphate buffer containing Triton X-100 (PBS-T; 10 mM NaPO4, pH 7.3, 140 mM NaCI, 10 mM EDTA, 10 mM benzamidine, 1 mM difluorophosphate, and 1% Triton X-100) by sonication at 4°C. Aliquots of lysate containing up to 100/xg of total protein were brought to 1% SDS and 1 mM /~-mercaptoethanol and heated to 100°C for 3 min. After cooling, the denatured lysates were mixed with an equal volume of 2 x endo F digestion buffer (Ix = 0.2 M NaPO4, pH 8.7, 0.75% NP-40, 5 mM EDTA, 5 mM o-phenanthrolene, and 0.5 mM PMSF). Peptide/N-glycanase (0.4 #g) was added and digestion was performed for 3 h at 37°C. An additional 0.1 #g of enzyme was added and digestion was continued for an additional hour. Controls for enzyme reactivity included the complete deglycosylation of an cq-acid glycoprotein. Reactions were terminated by the addition of 1/3 vol of4x SDS-PAGE sample buffer, then heated for 7 min at 100°C. Digested samples were analyzed by SDS-PAGE 10-20% gradient gels (Laemmli, 1970) . Proteins were transferred to nitrocellulose by the method of Towbin et al. (1979) . Membranes were blocked for 1 h in PBS-T containing 5% BSA. Rabbit anti-CEA Ig (DAKOPATTS, Copenhagen, Denmark) was used at 2 #g/m_l and goat anti-rabbit Ig alkaline phosphatase conjugate (Promega Biotec, Madison, WI) was used at a dilution of 1:7,500. Detection was by incubation of the membrane in 100 mM Tris-HCl, pH 9.5, 100 mM NaCI, 5 mM MgCI2 containing 66 mg/ml of nitro blue tetrazolium and 33 mg/ml of 5-bromo-4-chloro-3-indolyl phosphate.
Results
Isolation of TM-CEA cDNAs
Northern blot analysis was performed on poly A+ RNA from the L-cell transfectant line, 23.4 11+ that had been selected for the expression of CEA isoantigens (Kamarck et al., 1987) . Use of the CEA partial cDNA insert, LV7, as probe identified multiple hybridizing RNA bands with approximate molecular sizes of 3.9, 3.7, 2.2, and 1.8 kb (Fig.  1, lane a) . This pattern also recurs in the colon adenocarcinoma cell line HT-29 (Fig. 1, lane b) , which in addition expresses mRNAs for CEA (4.0 and 3.6 kb) and NCA (3.0 kb) (Barnett et al., 1988) . To clone the unidentified mRNAs, 3-4-kb double-stranded cDNA from 23.4 11+ poly A+ RNA was size selected and inserted into Xgtl0. A library of 8 x 10 ~ pfu was screened by LV7 hybridization. 13 phage were isolated, and the subcloned inserts from three of these, tc16-19 (3.6 kb), tc19-22 (3.5 kb), and tcE22 (3.3 kb), were analyzed by restriction endonuclease mapping. Insert tcE22 differed from the others by an apparent internal deletion of ,o 300 bp. Additional cDNAs were prepared from an HT-29 cDNA library that was size selected in the 1-3-kb region.
Based on the observation by Gold and Freedman (1965) that CEA is expressed during fetal development, we also screened.a cDNA library (2 × 105 pfu; Clontech Laboratories Inc., Pale Alto, CA) prepared from normal human fetal liver poly A + RNA with the CEA probe, LVT. Five positive recombinant phage were isolated and the inserts were subcloned into plasmid vectors. Two overlapping inserts, cFIA and cFL5, together comprised a 3.6-kb fetal liver cDNA identical in restriction map to tc16-19 and tc19-22. Fig. 2 shows the compilation of DNA sequences and deduced amino acid sequences from the inserts of plasmids ptcl6-19, ptc19-22, ptcE22, pcFL4, and pcFLS. These inserts together provided the longest open reading frame (nucleotides 73 to 1656) and the longest cDNA (3464 nucleotides). The compiled sequence codes for an apoprotein of 526 amino acids (Mr of 58 kD) with 19 potential extracellular N-linked glycosylation sites (Asn-X-Thr/Ser).
The coding sequence of the proposed apoprotein (designated TM1-CEA) demonstrates marked similarity to sequences found in CEA and NCA cDNA clones. This is indil~gure L Expression of CEA-related poly A+ RNAs. One-tenth microgram of CEA-transfectant 23.4 11+ poly A+ RNA (lane a) and two micrograms of coIon carcinoma cell line HT-29 poly A+ RNAs (lane b) were subjected to electrophoresis on a 2.2 M formaldehyde-0.8% agarose gel, transferred to nylon membrane, and hybridized with 32p-labeled LV7 DNA. cated by the proposed domain structure illustrated in Fig. 3 and by the sequence relationships detailed in Table I . As is typical for other CEA isoantigens, the TM1-CEA polypeptide initiates with a M-amino acid leader sequence that ends at a short side-chain amino acid, alanine. The proposed NH2-terminus of TM1-CEA contains glutamine as the first residue that initiates at 108-amino acid NH~-tenninal domain. This domain is identical in length and highly similar in sequence to the comparable domain of CEA and NCA ( Fig. 3 and Table I ). This is followed by a disulfide-loop domain (LD) that is a characteristic feature of CEA and is ,o178 amino acids in length (Oikawa et al., 1987) .
This domain differs from the single disulfide loop domains of immunoglobulins in that each one contains four cysteine residues capable of forming 47-and 39-amino acid disulfidelinked loops. Loop domains are repeated three times in CEA and once in NCA (Fig. 3) . The disulfide-loop domain size for TM1-CEA is similar to those of CEA and NCA, and the position of its cysteines is strictly conserved. In contrast to the domains of CEA and NCA, LD I of TM1-CEA has a fifth cysteine (residue 308; Fig. 2 ) that may not be involved in the formation of an intrachain disulfide loop.
An interesting structural region follows the conserved 177 amino acid loop-domain of TM1-CEA. This region, extending from nucleotides 1,030 to 1,340, codes for ,el00 amino acids and has the appearance of a "half" disulfide-loop domain (LD I/a of Fig. 3 ). This is indicated by comparison of amino acids that initiate loop domain regions in CEA, NCA, and TM1-CEA and by the characteristic positioning of its only two cysteine residues to form a 47-amino acid disulfide loop. While each of the disulfide-loop domains of the three CEA classes is highly conserved (,o70% amino acid similarity overall), LD IIa of TM1-CEA retains ~44 % amino acid similarity compared to TM1-CEA LD I (Table I) .
A 32-amino acid hydrophobic region comes after LD IIa and bears sequence similarity to the short hydrophobic tail that terminates CEA and NCA (Table I) . Hydropathy plot analysis supports the inference that this is a membranespanning region (data not shown). By contrast, the carboxylterminal region of TM1-CEA is composed of a hydrophilic stretch of 71 amino acids that terminates at residue 526 (nucleotide 1667). DNA Sequence of TM2-CEA. Insert tcE22, isolated from the 23.4 11+ eDNA library, presented a restriction map indistinguishable from TM1-CEA clones when a 300-bp gap was positioned within the molecule. DNA sequence analysis showed that tcE22 codes for a second TM-CEA species (TM2-CEA), which is identical to the TM1-CEA apoprotein with the exception of a 100-amino acid gap that corresponds exactly to LD IIa (Figs. 2 and 3) . We conclude that this cDNA accounts for the 3.7-kb mRNA observed in Fig. 1 and that it is derived by alternate splicing of the transcript that 
Identification of TM-CEA cDNAs Derived from Alternatively Spliced mRNAs
DNA Sequence of TM3-CEA. Northern analysis of poly
A+ RNAs indicated a prominent 2.2-kb RNA species when hybridized with LV7 probe DNA (Fig. 1) . cDNA from HT-29 poly A+ RNA yielded two partial clones that could be distinguished from TM1-and TM2-CEA cDNAs by restriction site analysis. Efforts to isolate full-length versions of TM3-CEA cDNA from the 23.4 11+ library were not suc- cessful. The DNA sequence of these partial cDNAs corresponds exactly to nucleotides 345-1,448 and 1,502-1,662 of TM1-CEA cDNA. The deletion of 53 bp between nucleotides 1448 and 1502 occurs in the DNA coding for the cytoplasmic region (shaded box of Fig. 2 ). As 53 bp is not a multiple of a codon triplet, nucleotides after 1,448 yield a new translation reading frame and generate a new cytoplasmic component for TM3-CEA (schematically drawn in Fig. 3) . The sequence indicates a translation of six new amino acids, followed by a TGA stop codon (nucleotide 1518). This results in a 9-amino acid cytoplasmic region for TM3-CEA compared to a 71-amino acid region for TM1-and TM2-CEA producing an apoprotein of 51 kD. A potential polyadenylation consensus sequence AATAAT (Wickens and Stephenson, 1984) in the 3' untranslated region (UTR) of TM3-CEA mRNA is found at a position that precedes a short run of oligo A nucleotides where the sequence diverges from that of TM1-and TM2-CEA. The likely polyadenylation site occurs in sequence that codes for the TM1-and TM2-CEA cytoplasmic domain.
DNA Sequence of TM4-CEA. Although we have yet to
obtain a representative cloned cDNA sequence, we speculate that there exists an additional TM-CEA molecule, TM4-CEA (calculated Mr of 40 kD), in which both LD Ha and the cytoplasmic region are alternatively spliced as in TM2-CEA and TM3-CEA, respectively (illustrated in Fig. 3 ). Experimental support for a fourth TM-CEA molecule comes from our observation of a 1.8 kb mRNA that is observed in Northern blots of 23.4 11+ cell mRNA (Fig. 1, lane a) . The estimated size of TM4-CEA mRNA without a poly A ÷ tail is 1.4 kb. As our size estimates for each of the TM-CEA RNAs by Northern blot analysis is consistently 300--400 bases longer than that of the cDNA, it is likely that the 1.8-kb RNA codes for TM4-CEA. 
Expression of TM-CEA cDNAs
To investigate the specific expression of TM-CEA mRNAs in tumor cells of different origins, we probed cellular RNAs with a cDNA probe derived from the cytoplasmic region of the TMI-CEA cDNA (CYTO probe; nucleotides 1,443-1,676). While some of these tumors express other CEA-isoantigen mRNAs based on hybridization to LV7 cDNA (Fig. 4 B, lanes a, b, and e), BeWo, SCaBER, and MIA PaCa-2 express only the transmembrane CEA isoantigen mRNAs (data not shown).
The Complete Transcription Unit of TM-CEA
We have reported the transfection of the TM-CEA transcription unit into primary and secondary L-cell transfectants (Kamarck et al., 1987) . To clone genomic segments corresponding to this transcription unit, a hJam recombinant DNA library of 2 × 106 independently derived recombinants were obtained from an Mbo I partial digest of transfectant cell 23.4 11+ DNA. 96 phage that hybridized with radiolabeled human DNA were plaque purified and a number of these phage isolates (M1, X22, and ),39) also hybridized with the LV7 probe. DNA inserts of these three phage ranged in size from 12 to 20 kb and contained the 5.3-kb Barn HI restriction segment shared by all of the primary and secondary L-cell transfectants (Kamarck et al., 1987) . Defined restriction fragments of TM1-CEA cDNA were subcloned for analysis of the genomic DNA. A 5' untranslated region probe (cDNA nucleotides 0-72) hybridized to genomic phage M1, X22, and ~39. A 3' UTR probe (3'UTR3; cDNA nucleotides 2,917-3,461) did not hybridize to these phage, but did identify two additional human recombinant phage (3`47 and 3,55) derived from the transfectant genomic library. Restriction site mapping demonstrated that all of the identified phage overlapped (Fig. 5, A and B) . Localization of the 5' and 3' UTR to genomic restriction segments indicated that the cDNA coding sequence is contained within •23 kb of genomic DNA (Fig. 5, B and C) . cDNA restriction segments defining structural domains within TM-CEA apoprotein were used to determine their location within genomic DNA (Fig. 5 C) . For example, cDNA sequences coding for the LD IIa structural domain (eDNA nucleotides 1017-1343; Fig. 2 ) were localized to a 3.8-kb Hind III genomic segment (Fig. 5 C) . In a similar manner, coding sequences for the leader and NH2,terminal domains (L-NH2), the first disulfide-loop domain (LD I), the transmembrane domain (TM), and cytoplasmic domains (CYT1 and CYT2) were localized to genomic restriction segments (Fig. 5 C) .
To look for other genomic sequences related to the TM-CEA cytoplasmic domain, the CYTO probe (nucleotides 1,443-1,676) was hybridized to a Southern blot of human genomic DNA cleaved with several restriction endonucleases. In contrast to the complex pattern obtained at high stringency with the domain probe LV7 (Kamarck et al., 1987) , hybridization performed even at reduced stringency (60°C; 6× SSPE) produced one band per lane indicating that there is a single cytoplasmic region in the genome (data not shown).
Delineation of Exon-Intron Boundaries
To support the evidence for alternative RNA splicing, we sequenced selected exon boundaries of the TM-CEA genomic DNA. For example, the 3' end of LD I was sequenced from a subclone of the 2.5-kb Bgl II genomic segment (Fig. 5 B) that hybridizes with the loop-domain probe, LV7. Doublestranded DNA sequencing using the dideoxy chain termination method was performed after extending an oligonucleotide primer from the 3' end of LD I, in this example, into adjacent intron sequence. A summary of selected exon-intron junction sequences is presented in Table II . Our data demonstrate that the structural domains defined as LD IIa, transmembrane, and cytoplasmic regions are coded for by discrete exons flanked by splice donor-acceptor sites. In addition, the nucleotide sequences of the exon-intron boundaries confirm the proposed location of junctions for alternative splicing based on the cDNA sequences of TM1-through TM4-CEA.
Biochemical Analysis of TM-CEA Isoantigens
Western immunoblot analyses, using a broadly reactive anti-CEA polyclonal antibody on lysates of 23.4 11+ cells, showed a complex array of antigens with molecular masses ranging from 50 to 150 kD (Fig. 6, lane A) . This result is consistent with the existence of multiple TM-CEA isoantigens displaying extensive N-linked glycosylation. To assess the number of different TM-CEA apoprotein species actually present, we subjected 23.4 11+ polypeptides to enzymatic deglycosylation with peptide/N-glycanase isolated from F. meningosepticum (Tarentino et al., 1985) . As shown in Fig.   6 , lane B, western analysis of deglycosylated transfectant cell proteins demonstrates the presence of four to five CEA isoantigen apoproteins. In contrast a lysate of control L cells shows no reactive species (Fig. 6, lane C) . The mobilities of the major bands in lane B are consistent with the molecular sizes of apoproteins calculated from translation of eDNA sequences: TM1, 58 kD; TM2, 47 kD; TM3, 51 kD; TM4, 40 kD. The presence of an apparent doublet for the smallest species is presently not explained, but may be due to inaccessibility of some N-linked oligosaccharides to enzyme.
Discussion
In the past 20 yr, an array of 8-10 CEA-related glycoproteins has been identified by biochemical methods in a variety of tumor and nontumor cells (for review see Shively and Beatty, 1985) . Recently, the genes for two members of this isoantigen family, CEA and NCA, have been cloned (Beauchemin et al., 1987; Oikawa et al., 1987; Barnett et al., 1988; Neumaier et al., 1988; Tawaragi et al., 1988) . In this study, we identify mRNAs, cDNAs, and a genomic transcription unit that encode novel CEA isoantigen members with transmembrane and cytoplasmic domains (TM-CEAs). Immunological data confirm that TM-CEAs are expressed at the cell surface. Although we cannot assign TM-CEA glycoproteins to previously identified CEA isoantigens (Shively and Beatty, 1985) , on the basis of molecular size we suggest that TM1-CEA may be related to the so-called "128K antigen" (Neumaier et al., 1985) .
We have shown that an L-cell secondary transfectant, 23.4 11+, and a number of tumor cell lines express a set of four RNA transcripts (3.9, 3.7, 2.2, and 1.8 kb) that are unrelated to CEA (4.0 and 3.6 kb) or NCA (3.0 kb) poly A+ RNAs. As the secondary transfectants likely contain a single genomic transcription unit, we proposed that these mRNAs represented the products of alternative RNA splicing (Kamarck et al., 1987) . The cDNA sequences of the TM-CEAs reported here, coupled with genomic DNA sequences at exonintron junctions, demonstrate that the mRNAs are indeed derived by alternative splicing from a single transcript. While TM1-CEA represents the largest transmembrane molecule, TM2-CEA lacks LD IIa, and TM3-CEA is defined by an alternate splice within the cytoplasmic domain, resulting in a unique intraceUular peptide sequence. The existence of an mRNA that contains both alternate splices, TM4-CEA, is supported by expression in the transfectants of a 1.8-kb poly A+ RNA (Fig. 1, lane a) and a 40-kD apoprotein (Fig. 6 ).
We also have cloned, as overlapping recombinant phage, the complete TM-CEA transcription unit which is encoded in ~23 kb of genomic DNA. Hybridization with cDNA probes indicates that structural domains defined by comparison with other CEA-related genes correspond to discrete exons (Fig. 5) . This was confirmed by the demonstration that regions adjacent to predicted exons are not found in cDNA and have consensus splice donor-acceptor sequences (Table  II) . These exon-intron junctions correspond exactly to the points of difference detected in the sequences of the alternatively spliced TM-CEAs.
Cell lines derived from colorectal tumors primarily produce CEA poly A+ RNA (Barnett et al., 1988) , consistent with their secretion of 180-kD CEA. Using specific cDNA probes we have demonstrated that TM-CEAs are also expressed by a number of these colorectal lines, in addition to other tumor types. In some cell lines, only the set of TM-CEA mRNAs are expressed (e.g., BeWo; Fig. 4, lane f ) , while in others, numerous CEA-related RNAs are additionally produced (e.g., HT-29; Fig. 1, lane b) . The expression of TM-CEAs is evidently not restricted to neoplastic tissue as TM1-CEA cDNAs have been cloned from an apparently normal fetal liver cDNA library. We cannot as yet correlate the expression of one or more CEA isoantigens with biological function, cellular morphology, substrate adhesion, or metastatic potential.
Members of the CEA isoantigen family display considerable nucleotide and amino acid sequence conservation (Table  I) . With the exception of the "half" disulfide loop-domain of TM1-CEA, all of the proposed extracellular regions are 1>70% similar at the amino acid level and >t80% similar at the nucleotide level. This explains the ability of the TMCEAs to be detected by several anti-CEA monoclonal antibodies and also illustrates the general cross-reactivity of anti-CEA immunoreagents.
Extracellular loop domains in CEA isoantigens demonstrate conserved amino acids surrounding the cysteine residues that are reminiscent of immunoglobulins and immunoglobulin superfamily proteins (HunkapiUer and Hood, 1986) . We have noted previously (Barnett et al., 1988) , and also observe here, the overall structural and amino acid similarity of all CEA glycoproteins to members of the immunoglobulin gene superfamily (Williams and Barclay, 1988) . This-family extends to cell surface recognition proteins (Thy-1 ] Williams and Gagnon, 1982] ), cell adhesion proteins (neural cell adhesion molecule [N-CAM; Cunningham et al., 1987] , ICAM [Simmons et al., 1988] , T cell erythrocyte receptor CD2 [Peterson and Seed, 1987] , and S-and L-MAG [Salzer et al., 1987; Arquint et al., 1987] ), receptor proteins (T4 receptor [Maddon et al., 1985] and PDGF receptor [Yarden et al., 1986] ), and oncogenes (CSF-1 receptor/v-fms [Hampe et al., 1984] ). Although their ligands have not yet been identified, we propose by analogy that members of the CEA isoantigen family act as cell surface recognition proteins.
This analogy can be extended to the alternative structural forms of neural cell adhesion molecule (N-CAM) and myelinassociated glycoprotein (MAG). Three different N-CAM isoantigens are generated from a single genomic segment (Cunningham et al., 1987) : the ssd form, with a short hydrophobic COOH-terminus (like CEA and NCA), the sd form, with a short cytoplasmic domain (like TM3/4-CEA), and the /d form, with a longer cytoplasmic domain (TM1/2-CEA). Two cytoplasmic forms of MAG (S-MAG and L-MAG) have also been described (SaLzer et al., 1987) . For MAG, N-CAM, and TM-CEA, the alternative cytoplasmic regions are derived by differential splicing of those exons that code for intracellular peptide segments. A novel N-CAM has been described recently in human skeletal muscle where the ssd form contains a previously unidentified 37-amino acid extracellular domain (Dickson et al., 1987) . This may compare with the TM1-and TM3-specific "half' disulfide-loop in these forms of CEA.
Alternative forms of the cytoplasmic region of N-CAM and L-MAG are derived by appropriate splice selection of inframe exons (Cunningham et al., 1987; Salzer et al., 1987) . In contrast, TM3-CEA and the proposed TM4-CEA contain a short but novel cytoplasmic peptide generated by a splice that results in out-of-frame translation. With this splice, the coding sequence for TM1/2-CEA cytoplasmic region becomes the 3' UTR and also contains the consensus polyadenylation sequence (Figs. 2 and 3 ). To our knowledge, this result is unique among alternatively spliced RNAs. Unusual alternate COOH-terminal splices accompany the synthesis of the glial and endothelial cell forms of platelet-derived growth factor A chain (Tong et al., 1987; Bonthron et al., 1987) and of the hydrophobic and hydrophilic termini of decay accelerating factor (Caras et al., 1987) , but in each case, the 3' untranslated sequence and polyadenylation site remains constant.
The cytoplasmic domain of TM-CEA is unique, as it is represented as a single band in Southern bl0t genomic analysis and bears no significant resemblance to other CEA-or non-CEA-related sequences based on computer-aided searches The carboxyl-terminal residues of L-MAG and TMI-/TM2-CEA are shown; the absolute COOH-terminus for each is on the right. Regions of identity or similarity are indicated, respectively, by a solid line (I) or an asterisk (.) extending between compared residues. For best physical alignment, deletion of some amino acids in TM-CEA relative to L-MAG is required; this is indicated by ,~.
of the GenBank or EMBL data bases, or by direct comparison of 20 different immunoglobulin superfamily members. However, a segment of limited similarity has been detected between the COOH-terminal 44 amino acids of the TM1/ TM2-CEA cytoplasmic domain and the COOH-terminal 38 amino acids of the L-MAG cytoplasmic domain (19/38 amino acids; Fig. 7 ). This cytoplasmic segment is relatively high in amino acids that are potential substrates for phosphorylation i.e., serine, threonine, and tyrosine (13/48 residues), and it is largely these amino acids that are shared between the molecules. Consensus signals for associated enzymatic activities like tyrosine kinase (Bairoch and Claviere, 1988) are not found.
In Fig. 8 , we illustrate our interpretation of the extensive structural similarity among CEA isoantigens using immunoglobulin molecules as a model for their organization (Hunkapiller and Hood, 1986) . CEA isoantigens are depicted l   NCA  CEA  TM1  TM2  TM3  TM4   TM1  TM2-TM1 homodlmet heterodlmer Figure 8 . Hypothetical single chain and dimer forms of CEA isoantigens as immunoglobulin-like molecules. Each CEA family member is depicted with extracellular disulfide loops and is embedded in the lipid bilayer via phosphoinositol linkage (for CEA and NCA) or is an integral cell surface molecule (for TM-CEAs). Some TM-CEA members are depicted as homo-or heterodimers.
as membrane bound: for CEA and NCA, the membrane attachment may occur via a phosphoinositol glycan moiety (Takami et al., 1988) , while the TM-CEAs have structural domains that make them integral membrane glycoproteins. While we depict all CEA isoantigens as single polypeptide chains, sequence analysis of the TM-CEAs indicates that these proteins have the potential to exist in vivo as cell surface homo-or heterodimers. LD I of TM-CEAs contains a single cysteine residue (amino acid position 308; Fig. 2 ) that may not be involved in intrachain disulfide linkage and therefore by analogy, TM-CEA homodimers and heterodimers are depicted as immunoglobulin-like in surface character.
